BackRocket Pharmaceuticals- Warrants (02/09/2026) Overview

Rocket Pharmaceuticals- Warrants (02/09/2026) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for RCKTW.

Quarterly EBIT

-$48.51M
20.29% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$208.43M
21% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)